SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hyperliquid Strategies, Inc. is a holding and operating company, which engages in the business of crypto asset management. The firm operates as a digital asset treasury company which focuses on the Hyperliquid ecosystem. The company was founded on July 2, 2025 and is headquartered in New York, NY.

Hyperliquid Strategies Inc.

Hyperliquid Strategies is gaining significant attention as investors speculate on its position as a digital asset infrastructure play, with the community actively tracking its correlation to the HYPE token and the broader rise in perpetual futures trading. Discussions are dominated by potential institutional interest and the stock's role as a crypto-equity hybrid, despite ongoing debates regarding dilution and its historical performance.

Zoracles

Zoracles is drawing significant attention as investors speculate on potential price rebounds, with many viewing current pullbacks as strategic accumulation opportunities. The community remains focused on the token's integration with the Base ecosystem and its potential utility as a creator-focused asset, despite broader market volatility and mixed sentiment regarding its short-term price action.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is trending as investors focus on the company's oncology pipeline following major data updates from the HARMONi-6 trial and its upcoming PDUFA date. The community is actively debating the potential for ivonescimab to challenge existing standards of care, with sentiment split between bullish enthusiasm over clinical results and concerns regarding trial design and regulatory pathways.

Gitlawb is a decentralized code collaboration platform designed for AI agents and human developers. It provides a Git-compatible hosting layer where repositories are stored across IPFS, Filecoin, and Arweave, and peer connectivity is handled through libp2p rather than a central server.  Identity on Gitlawb is based on decentralized identifiers (DIDs) using Ed25519 keys. Access control and delegation between users and agents are expressed as UCAN (User Controlled Authorization Networks) capabilities, allowing scoped, revocable permissions to be granted without a central authority. Each identity carries an on-chain trust score derived from verified contributions.  The protocol is accessed through three main surfaces: a Rust node (gitlawb-node) that serves repositories over HTTP and libp2p, a command-line client (gl) that handles identity, repositories, issues, bounties, and UCAN delegation, and a git remote helper (git-remote-gitlawb) that allows standard Git clients to push and pull using gitlawb:// URLs.  Additional products in the ecosystem include MiroClaw, an on-chain prediction market; Gitlawb Spawn, an AI agent orchestration tool; OpenClaude, an open-source agent harness aligned with Playground and Spawn; and a developer playground for testing agent interactions against the protocol.

Gitlawb

Gitlawb is trending as investors highlight its vision as a decentralized, AI-native alternative to GitHub, specifically designed for autonomous agents to manage repositories and coordinate tasks on-chain. The community is actively discussing the project's aggressive supply reduction plans, potential exchange listings, and strategic partnerships, with many focusing on its long-term utility in the evolving AI infrastructure stack.

Avalanche is a high throughput smart contract blockchain&nbsp;platform. Validators secure the network through a proof-of-stake consensus protocol. It is said to be fast, low cost, and environmental friendly.

Avalanche

Avalanche is facing intense selling pressure as it hits multi-year lows, triggering widespread frustration among community members who are debating whether to hold through the volatility or capitulate at a loss. Sentiment is heavily polarized between long-term investors emphasizing fundamental RWA adoption and institutional integration, and traders highlighting the lack of short-term price momentum.

Chronobank

Chronobank is currently generating significant community buzz due to a recent security incident involving the unauthorized minting of tokens, prompting the company to initiate buybacks and burns to stabilize supply. Investors are closely monitoring the asset's low circulating supply and potential for volatility, with many debating whether it functions as a long-term utility play or a speculative pump-and-dump opportunity.

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

BioNTech SE - ADR

BioNTech is trending due to the company's recent strategic pivot away from COVID-19 revenue toward a diversified oncology pipeline, which includes multiple late-stage clinical trials. Community sentiment is mixed, with some investors optimistic about the potential of their bispecific antibody and ADC programs to disrupt the standard of care, while others remain skeptical about the leadership transition and the long-term viability of mRNA technology.

TKO Group Holdings, Inc. engages in the provision of sports and entertainment. It operates through the following segments: Ultimate Fighting Championship (UFC), World Wrestling Entertainment (WWE), and IMG. The UFC segment refers to a global sports brand and media content company. The WWE segment is involved in media organizations and global leaders in sports entertainment. The IMG segment manages the operations of the IMG business and on location. The company was founded on March 29, 2023 and is headquartered in New York, NY.

TKO Group Holdings Inc - Ordinary Shares - Class A

TKO GROUP HLDGS INC

TKO Group Holdings is trending as investors weigh significant growth catalystsincluding S&P 500 inclusion, a massive share buyback program, and the expansion of the companys streaming reachagainst vocal community frustration over ticket pricing, content fatigue, and controversial management decisions. While bulls highlight robust earnings and a clear long-term trajectory anchored by UFC and WWE, bears remain focused on potential accounting concerns and broader market volatility impacting the stock's recent momentum.

Li Auto, Inc. engages in the design, development, manufacture, and sale of premium smart electric vehicles. Its products include Li MEGA, a high-tech flagship family MPV, Li L9, a six-seat flagship family SUV, and Li L8, a six-seat premium family SUV, and Li L7, a five-seat flagship family SUV. The firm also offers in-house development efforts on its proprietary range extension system, next-generation electric vehicle technology, and smart vehicle solutions. The company was founded by Xiang Li in April 2015 and is headquartered in Beijing, China.

Li Auto Inc - ADR

Li Auto Inc is currently under intense scrutiny from the investment community as shareholders brace for quarterly earnings, with concerns centering on margin pressure and slowing delivery momentum. Discussions are dominated by debates over the company's competitive position against rivals like Nio, skepticism regarding its pivot toward battery-electric vehicles, and market reactions to a softer delivery outlook.

Select Sector SPDR Trust (The) - State Street Consumer Staples Select Sector SPDR ETF

Consumer Staples Select Sector SPDR Fund

The Consumer Staples sector is seeing increased attention as investors rotate toward defensive assets amid growing market volatility and inflation concerns. Community discussion is currently centered on these stocks acting as a potential safe haven while participants monitor broader sector rotation patterns.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ResMed (RMD) is a Top-Ranked Growth Stock: Should You Buy?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Is the Options Market Predicting a Spike in ResMed Stock?

Investors need to pay close attention to RMD stock based on the movements in the options market lately.

Silver Economy Investing: Why the Healthcare Giants Are in Focus

Healthcare giants like Eli Lilly, Tandem Diabetes, Intuitive Surgical and ResMed are tapping aging-driven demand in obesity, surgery and sleep care.

Here's Why ResMed (RMD) is a Strong Growth Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Birch Capital Management LLC Reduces Stock Holdings in ResMed Inc. $RMD

Birch Capital Management LLC reduced its stake in shares of ResMed Inc. (NYSE:RMD - Free Report) by 24.3% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 26,899 shares of the medical equipment provider's stock after selling 8,642 shares du...

PFA Pension Forsikringsaktieselskab Buys Shares of 188,393 ResMed Inc. $RMD

PFA Pension Forsikringsaktieselskab bought a new stake in ResMed Inc. (NYSE:RMD - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities...

ResMed Q3 Earnings Call Highlights

ResMed (NYSE:RMD) reported third-quarter fiscal 2026 results highlighted by revenue growth, gross margin expansion, and higher non-GAAP earnings per share, while also announcing a CFO transition and a planned tuck-in acquisition to expand beyond its core sleep apnea business.

Leadership updates: CF...

Royal Bank Of Canada Forecasts Strong Price Appreciation for ResMed (NYSE:RMD) Stock

Royal Bank Of Canada lifted their price target on ResMed from $314.00 to $321.00 and gave the company an "outperform" rating in a research report on Friday...

ResMed (NYSE:RMD)  Shares Down 6%  on Analyst Downgrade

ResMed (NYSE:RMD) Shares Down 6% Following Analyst Downgrade...

Wells Fargo & Company Issues Pessimistic Forecast for ResMed (NYSE:RMD) Stock Price

Wells Fargo & Company lowered their price target on shares of ResMed from $270.00 to $227.00 and set an "equal weight" rating on the stock in a report on Friday...

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases. The firm operates through the Sleep and Respiratory Care and Software as a Service segments. The Sleep and Respiratory Care segment engages in the sleep and respiratory disorders sector of the medical device industry. The Software as a Service segment provides business management software as a service to out-of-hospital health providers. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '26	$2.89	--	--	N/A
Q3 '26	$2.80	$2.86	2.32%	BEAT
Q2 '26	$2.74	$2.81	2.73%	BEAT
Q1 '26	$2.52	$2.55	1.32%	BEAT
Q4 '25	$2.49	$2.55	2.32%	BEAT

RMD
Resmed Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '26

Historical Earnings

Compact View

Latest RMD News

RMDResmed Inc.